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Abstract: The properties and the production of new metabolites from the fungal strain LF657 isolated
from the Herodotes Deep (2800 m depth) in the Mediterranean Sea are reported in this study. The new
isolate was identified as Biscogniauxia mediterranea based on ITS1-5.8S-ITS2 and 28S rRNA gene
sequences. A new isopyrrolonaphthoquinone with inhibitory activity against glycogen synthase
kinase (GSK-3β) was isolated from this fungus. This is the first report of this class of compounds
from a fungus isolated from a deep-sea sediment, as well as from a Biscogniauxia species.
Keywords: marine fungi; glycogen synthase kinase; acetylcholinesterase; Biscogniauxia mediterranea;
deep sea
1. Introduction
An enormous number of natural products have been isolated and identified from marine
microbiota, but deep-sea marine microorganisms remain an almost untapped resource [1]. As methods
for sample collection, identification, and culturing technologies of deep-sea microorganisms have
advanced significantly in recent years, a shift of foci from shallow water to the deep sea for natural
product chemists has come along [2]. During studies on the diversity of fungi in the deep Mediterranean
Sea and also on sponges, in particular in Tethya aurantium [3], a valuable tool for the identification
of fungal isolates proved to be the combination of morphological criteria and the comparison of
the ITS1-5.8S-ITS2 fragment sequences [3,4]. In particular, the sequence information gave valuable
additional information for the phylogenetic evaluation of the investigated isolates. Our studies
with sediments from the deep Mediterranean Sea have shown the dominance of representatives
of Aspergillus and Penicillium (almost half of all isolates) together with isolates from 10 other genera,
including strain LF657 as a single isolate (out of a total of 43) of Biscogniauxia [4]. This Biscogniauxia
isolate was obtained from sediments of the Herodotes Deep (2800 m depth) in the Mediterranean
Sea and properties of this fungus and the production of metabolites are reported in the present study.
A new isopyrrolonaphthoquinone was identified in extracts of the Biscogniauxia isolate together with
a known isocoumarin and a known cyclopentapeptide. As reviewed by Piggott (2005), the natural
product backbones of isofuranonaphthoquinones and related compounds comprise a small group of
secondary metabolites isolated from fungi, plants, bacteria, and insects, and these compounds have
a broad spectrum of biological effects, such as antibiotic, antioxidant, or antiplasmodial activities
as well as cytotoxicity towards tumor cell lines and inhibition of the myosin light-chain kinase [5].
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Here we report the first discovery of an isopyrrolonaphthoquinone compound from a fungus isolated
from deep-sea sediment.
2. Results
2.1. Sampling, Isolation, and Identification of Strain LF657
During the Meteor 71/2 cruise to the Eastern Mediterranean Sea, samples were collected from
the sediment of the Herodotes Basin (2800 m water depth), diluted in sterile Mediterranean Sea
water, and plated onto five different media with the aim to isolate bacteria and fungi. Strain LF657
was obtained from a sample taken from the top sediment layer (0 to 0.5 cm depth) after cultivation
on a low-nutrient “Cytophaga-Flavobacterium-Bacteroides” (CFB) agar. The isolate grew well on
Wickerham agar medium containing 3% sodium chloride and also on glucose-peptone-yeast extract
agar supplemented with sea water with an approximately 3.5% salt concentration with a colony
diameter of 100 mm after 10 days of incubation at 26 ◦C (Figure 1). No reproductive structures were
observed, which would enable the identification on a morphological basis.
The fungus was identified by its ITS1-5.8S-ITS2 gene fragment sequence (506 nucleotides),
which was 99.1% identical to several Biscogniauxia mediterranea strains, such as B. mediterranea G19
(acc. No. KT364486), B. mediterranea CCTU125 (acc. No. KX267752), and B. mediterranea BM07.003
(acc. No. FR734187). Also the 28S rRNA gene sequence (837 nucleotides) revealed members of
Biscogniauxia mediterranea as the next related strains. Among them were B. mediterranea Bm12.022
(acc. No. KM216771) with a similarity of 100% and B. mediterranea AS (acc. No. KR909208) with
99.5% similarity. Therefore, strain LF657 was classified as Biscogniauxia mediterranea (Sordariomycetes,
Xylariales, Xylariaceae). The sequences of the ITS1-5.8S rRNA-ITS2 gene fragment and of the 28S rRNA
gene fragment from LF657 were submitted to the Genbank database and were assigned to accession
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Figure 1. Colony of Biscogniauxia mediterranea strain LF657 grown on Wickerham agar (26 ◦C, 10 days).
Biscogniauxia was first described by Kuntze [6] and is a genus assigned to the family Xylariaceae.
Biscogniauxia species are kno plant pathogens, which typically ar bark parasites and are able
to degrade major components of the wood, cellulose an lignin. Thoug Biscogniauxia mediterranea
became known as the causative agent of charcoal canker in Mediterranean cork oak, it appears not
to be host specific and apparently is distributed worldwide [7,8]. There is no evidence so far on
the occurrence of Biscogni uxia sp ci s in marine aters or even in the deep sea. A recent study
using 5.8S rRNA gene and ITS2 sequences with a larger number of isolates has given interesting
insight into the phylogeny of the Xylariaceae family [7]. With some exceptions, this phylogenetic
analysis showed a reasonable degree of correlation with the classification based upon morphological
properties. A reevaluation of the phylogenetic relationship of the Xylariaceae was performed on the
basis of sequences of several genes, including those coding for ß-tubulin, the second largest subunit of
Mar. Drugs 2016, 14, 204 3 of 9
RNA polymerase II (RPB2), and the large subunit ribosomal RNA (LSU rDNA). This study revealed
a separate common lineage of Biscogniauxia and Camillea species, which are usually considered to be
very closely related genera if not synonyms, and clearly indicated their separation from other clades of
this family [8]. The position of Biscogniauxia in both studies was fully consistent with the morphological
and chemotaxonomic characters that assimilate this genus to the Xylariaceae.
2.2. Structural Elucidation
The MeOH extracts of the culture broth and the mycelia of strain LF657 were subjected
to HPLC-DAD(UV)-MS analysis, revealing more than 10 compounds. Applying preparative
HPLC (C18), seven compounds were isolated. Among them, a new isopyrrolonaphthoquinone 1,
together with a known isocoumarin, 6-methoxy-5-methyl mellein (2) [9], and a cyclopeptide,
cyclo-(L-Phe-L-Leu-L-Val-L-Leu-L-Leu) (3), a previously synthesized derivative of the fungal metabolite
sansalvamide A, were identified [10,11] (Figure 2). Those three compounds were detected in both the
mycelium and the culture broth, but the yields were higher in the mycelium extract. The production of
derivatives of compound 1 by strain LF657 is expected because of the presence of metabolites with
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Figure 2. The structures of the compounds identified from Biscogniauxia mediterranea strain LF657.
ompound 1 wa is lat d as a brown powder. The molecular formula was determined to be
C12H7NO4 by analysis of the HR-TOF-MS ion peak at m/z 252.0277 [M + Na]+ (calcd. 252.0267).
The 1H and 13C NMR spectra of 1 (Table 1) showed similar chemical shifts and the same
multiplicities for 12 carbon atoms of rings A, B and C as compared to the known compound
monosporascone with a minor difference, indicating that compound 1 supposedly possesses the
basic structure of a naphtho[2,3-c]furandione (isofuranonaphthoquinone), a minor natural compound
class. Both isobenzofuran and benzofuran substructures exist in nature, with the benzofuran
found in the majority of structures. The characteristic proton signals at δH 7.70 (overlap, dd,
J = 3.1, 1.6 Hz) for two protons in the furan rings in the 1H NMR spectrum of 1 and the
HMBC cross-peaks from this over a ped proton signals to both carbonyl carbons at δC 179.1 and
185.2 were observed. This indicated the presence of the isobenzofuran-4,7-dione instead of
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a benzofuran. Two main subclasses exist among the hitherto known naphtho[2,3-c]furandinone natural
products. One includes naphtho[2,3-c]furan-4(9H)-ones with two carbonyls at the 5 and 8 positions,
which often undergo a tautomeric relationship with naphtho[2,3-c]furan-4-ols [5]. Another contains
naphtho[2,3-c]furan-4,9-diones with two carbonyls at the 4 and 9 positions. To clarify the position of
the two carbonyls in the supposed isofuranonaphthoquinone ring system and the substitution pattern,
detailed 2D NMR experiments were carried out. The long-range correlations from the aromatic proton
at δH 7.06 (d, J = 2.4 Hz, H-8) and the isobenzofuran proton at δH 7.70 to the same carbonyl carbon
at δC 179.1 (C-9) suggested the presence of a naphtho[2,3-c]furan-4,9-dione backbone. Two aromatic
proton signals at δH 6.47 and 7.06 were deduced to be meta to each other from the analysis of their
coupling constant value of 2.4 Hz and the HMBC cross-peaks of H-6/C-4a, H-6/C-5 and H-8/C-8a.
The OH signal at δH 13.27 was positioned at C-5 since it showed a sharp singlet which derived from
the intramolecular hydrogen bond with the remaining C=O at δC 185.2. Thus, another hydroxyl
must locate at C-7 which was also confirmed by the HMBC cross-peaks of H-6,8/C-7. Although the
1H NMR data of 1 exhibited good similarity to a number of isofuranonaphthoquinone compounds [12],
two supposedly furan CH resonances at C-1 and C-3 were observed to upshift approximately
23 ppm, which implied a NH instead of an O linkage between C-1 and C-3. This inference also
was supported by the HR-TOF-MS results and indicates the presence of an N atom in the molecule of 1.
Only few known compounds possess the N-containing isopyrrolonaphthoquinone structures, such as
azamonosporascone [12], bhimamycin C and D [13] as well as bhimamycin F, H, and I [14]. According to
the established data (Figure 3, Table 1), compound 1 was identified as a new N-atom-containing
isopyrrolonaphthoquinone compound named biscogniauxone. As furanes are easily transformed into
pyrroles by a reaction with primary amines [13], the isopyrrolonaphthoquinone may derive from its
isofuranonaphthoquinone precursor. The 1H and 13C NMR spectra of compound 1 including COSY,
HMQC, HMBC and HRESIMS are given in the supplementary material (Figures S1–S7), the complete
NMR signal assignments are listed in Table 1.
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Table 1. NMR spectroscopic data (500 MHz, DMSO-d6) of compound 1.
Position δC a,b δH c Mult. (J in Hz) HMBC d
1 123.9, CH 7.70, overlap, dd (3.1, 1.6) 3, 9a, 9
3 124.4, C




6 107.3, CH 6.47, d (2.4) 4a, 5
7 165.4, C
8 108.4, CH 7.06, d (2.4) 7, 8a, 9
8a 138.2, C
9 179.1, C
9a 122.0 e, C
5-OH 13.27, s
a Recorded at 125 MHz; b Multiplicities inferred from DEPT and HMQC experiments; c Recorded at 500 MHz;
d Proton showing long-range correlation with indicated carbons; e interchangeable.
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2.3. Biological Activities
The most important activities observed for the new compound 1 were inhibiting glycogen
synthase kinase (GSK-3β) with an IC50 value of 8.04 µM (±0.28) and the known cyclopentapeptide (3)
showing an inhibitory effect on acetylcholinesterase (AchE) by a minimal inhibition concentration
(MIC) of 5.87 µM (±0.74). Positive controls were 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
(TDZD-8) for GSK-3β, which revealed an IC50 value of 0.26 ± 0.03 µM, and huperzine for AchE with
an IC50 value of 0.012 µM (±0.0009). Compound 1 very weakly inhibited the growth of Staphylococcus
epidermidis and methicillin-resistant Staphylococcus aureus with IC50 values in the range of 100 µM,
respectively. Septoria tritici and Trichophyton rubrum were weakly inhibited by compound 2 in the same
concentration range.
3. Discussion
In view of their parasitic-pathogenic nature, the production of bioactive compounds and, in
particular, of phytotoxic substances has been studied in a number of Biscogniauxia strains, and several
bioactive substances have been described for the first time from these fungi. A new phytotoxic
biscopyran is produced by Biscogniauxia mediterranea together with phenylacetic acid and the
isocoumarin 5-methylmellein [15]. Two new azaphilone derivatives, biscogniazaphilones A and B,
with antimycobacterial activity were produced by Biscogniauxia formosana together with nine known
compounds [16]. In addition, two new substances, biscognin A and B, were found in extracts of
B. mediterranea [17]. The new guaiane sesquiterpene xylaranone and the known terpenoid xylaranol
B (together with mellein derivatives) were isolated from Biscogniauxia nummularia. They revealed
antigerminative activity against seeds of Raphanus sativus [18].
In extracts of B. mediterranea strain LF657, isolated from a deep-sea sediment of the Eastern
Mediterranean Sea at 2800 m water depth, the new isopyrrolonaphthoquinone compound
biscogniauxone (1) was identified and found to exhibit inhibitory activity against the enzyme GSK-3β,
which is an important target for the treatment of diseases such as diabetes type 2, neurological disorders,
and cancer [19–21].
In addition to biscogniauxone (1), two further metabolites were identified: a mellein derivative,
identified as 6-methoxy-5-methyl mellein (2), and the cyclic pentapeptide cyclo-(L-Phe-L-Leu-L-Val-L-
Leu-L-Leu, sansalvamide A amide (3). Compound 3 (C32H51N5O5) is structurally very similar to the
cyclic pentadepsipeptide sansalvamide A (C32H50N4O6), which contains leucic acid (Oleu) instead
of leucin in comparison to compound 3 [11]. Sansalvamide A was found in extracts of a Fusarium
isolate obtained from the marine seagrass Halodule wrightii. Because of promising cytotoxic effects on
several cancer cell lines, sansalvamide A as well as a sansalvamide A amide and derivatives of both
compounds were synthesized [22]. It was shown that improved activities against the drug-resistant
colon cancer cell line HCT-116, the interaction with the key oncogenic protein Hsp90, as well as
the ADME (adsorption, distribution, metabolism, excretion) properties were obtained with some
derivatives, especially with (R,R)betaOH(Bn)-Phe-Leu-N-Me-Val-D-Leu-D-Phe [22].
4. Experimental Section
4.1. General Experimental Procedures
1H NMR (500 MHz) and 13C NMR (125 MHz) spectra were measured at 25 ◦C on a Bruker
(Bremen, Germany) AVANCE DMX 500 NMR spectrometer with tetramethylsilane (TMS) as internal
standard. The signals of the residual solvent protons and the solvent carbons were used as internal
references (δH 2.5 ppm and δC 39.5 ppm for DMSO-d6 (compound 1), δH 3.31 ppm and δC
49.0 ppm for methanol-d4 compound 2 and 3). High-resolution mass spectra were acquired on
a benchtop time-of-flight spectrometer (micrOTOF II, Bruker Daltonics, Bremen, Germany) with
positive electrospray ionization (ESI).
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4.2. Isolation, Cultivation, and Storage of the Producer Strain LF657
Strain LF657 was obtained from a sample collected during the cruise Meteor 71/2 in December
2006 to January 2007 to the Eastern Mediterranean Sea from the top sediment layer (0 to 0.5 cm
depth) of the Herodotes Basin at 2800 m water depth [23]. The Herodotos Basin is a large basin in
the most oligotrophic eastern part of the Mediterranean Sea extending southwestern from Cyprus
Island. Sediment samples from one of the sampling sites (33◦42.989 N, 26◦20.329 E) were taken with
a multi corer, subsampled aseptically, diluted 10−1 to 10−4 in sterile Mediterranean Sea water and
spread onto five different agar media [23]. Strain LF657 was isolated from a 10−1 dilution plated
onto Cytophaga-Flavobacterium-Bacteroides medium (0.1% BBL™ (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA) tryptone, 0.05% Bacto™ (Becton, Dickinson and Company, Franklin Lakes,
NJ, USA), yeast extract, 0.05% CaCl2·2H2O, 0.05% MgCl2·7H2O, and 1.5% Bacto™ agar dissolved
in Mediterranean Sea water, pH = 7.0). Sub-cultivation was performed using glucose-peptone-yeast
extract agar medium (GPY; 0.1% glucose, 0.05 peptone, 0.01% yeast extract, and 1.5% Bacto™ agar
dissolved in sea water; pH = 7.2–7.4) and a modified Wickerham-medium (WSP30; 1% glucose,
0.5% peptone, 0.3% yeast extract, 0.3% malt extract, 3% sodium chloride, and 1.5% Bacto™ agar;
pH = 6.8) [24]. The isolate is stored in liquid nitrogen and in addition at −80 ◦C using the
CRYOBANK™system (MAST Diagostika GmbH, Reinfeld, Germany).
4.3. Identification of the Strain LF657
The genetic characterization of the fungus was performed by the analysis of the ITS and
28S rRNA gene sequences. DNA-extraction, amplification of the ITS1-5.8S rRNA-ITS2 fragment,
and sequencing procedure were carried out according to Wiese et al. [3]. Amplification of the
28S rRNA gene fragment was processed as described by Wu et al. [25]. Briefly, the fungal cells were
raptured by homogenization by using glass beads and the Precellys 24 system (Bertin Technologies,
Montigny-le-Bretonneux, France). The suspension was centrifuged at 6000× g for 10 min and the
supernatant was stored at −20 ◦C. This DNA extract was used as template for amplification of the
desired gene fragments applying the following primers: ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′)
and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) for the ITS1-5.8S rRNA-ITS2 fragment as well
as 5.8SR (5′-TCGATGAAGAACGCAGCG-3′) and LR7 (5′-TACTACCACCAAGATCT-3′) for the
28S rRNA gene fragment, respectively [26,27]. Sequencing of the amplicons was performed with
the primers ITS1 and ITS4 as well as with LR0R (5′-ACCCGCTGAACTTAAGC-3′) and LR5
(5′-TCCTGAGGGAAACTTCG-3′), respectively [28]. Closest relatives were identified by sequence
comparison with the NCBI Genbank database using BLAST (Basic Local Alignment Search Tool) [29].
Sequence similarity values were determined with the “bl2seq” tool of the NCBI database [30].
4.4. Fermentation and Production of Extracts for the Purification of Compound 1, 2, 3
Strain LF657 was inoculated onto agar plates containing WSP30 medium. After incubation for
13 days at 26 ◦C the pre-culture was used as inoculum of Erlenmeyer flasks containing 750 mL SM
medium (2% soy peptone, 2% mannitol, 1.5% Tropic Marine Salt, pH 7.0). The flasks were incubated
for 16 days at 28 ◦C as static cultures in the dark. The mycelium was separated from the culture broth.
The 4.5 L fermentation broth was extracted using ethyl acetate (2.4 L). The upper phase was evaporated
to dryness. The residue was dissolved in 5 mL methanol to obtain the extract of the culture broth.
The mycelium was extracted by adding 0.9 L of ethanol and homogenizing using an ultra-turrax.
After centrifugation at 10,000 rpm for 10 min, the supernatant was collected and evaporated to dryness.
The resulting residue was dissolved in 5 mL methanol to get the extract of the mycelium. Crude extracts
were stored at 4 ◦C until further use.
4.5. Extraction and Isolation of Compounds 1
Analytical reversed phase HPLC-DAD(UV)-MS experiments were performed using a C18 column
(Phenomenex (Torrance, CA, USA) Onyx Monolithic C18, 100× 3.00 mm) applying an H2O/acetonitrile
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(ACN) gradient with 0.1% formic acid added to both solvents (gradient: 0 min 5% ACN, 4 min
60% ACN, 6 min 100% ACN; flow 2 mL/min each; 6.1 min 100% ACN, 6.8 min 100% ACN, 7.0 min
5% ACN, 8.2 min 5%; flow 2.5 mL/min each) on a VWR Hitachi (Darmstadt, Germany) Elite
LaChrom system with an L-2450 diode array detector, an L-2130 pump, and an L-2200 autosampler
(VWR, Darmstadt, Germany). The system was coupled to an ESI-ion trap detector with positive
ionization (Esquire 4000, Bruker Daltonics, Bremen, Germany) for mass detection.
The preparative HPLC was conducted with a HPLC-UV system (LaPrep, pump P110, UV detector
P311, smartline 3900 autosampler (VWR International, Darmstadt, Germany)) coupled with
a LABOCOL Vario-2000 fraction collector (LABOMATIC, Weil am Rhein, Germany) using a C18 column
(Phenomenex Gemini-NX C18 110A, 100 mm × 50mm). Purification of compound 1 was performed
with a gradient from 10% (0 min) to 15% (30 min) acetonitrile (ACN) and a flow of 15 mL/min yielding
10.0 mg (tR 9.1 min). Compound 2 and 3 were purified applying the following gradient parameters:
0 min 10% ACN, 17.5 min 60% ACN, 22 min 100% ACN at a flow of 100 mL/min. The yield of 2 was
32.1 mg (tR 16.8 min) and of 3 213.9 mg (tR 19.8 min).
Biscogniauxone (1) had the following properties: white powder; UV (MeOH) λmax (log ε)
254 (4.17), 396 (3.80) nm; 1H NMR and 13C NMR, see Table 1; ESIMS m/z 252 [M + Na]+; HR-TOF-MS
m/z 252.0277 [M + Na]+ (calcd. for C12H7NO4Na, 252.0267).
4.6. Biological Activities Assays
The antimicrobial activities of compounds 1 and 2 against the bacteria Bacillus subtilis as
well as the human pathogenic yeast Candida albicans (DSM 1386) were determined according to
Ohlendorf et al. [31]. The bioassays with the clinically relevant bacterial strains Staphylococcus epidermidis
(DSM 20044), methicillin-resistant Staphylococcus aureus (MRSA) (DSM 18827), and the causative
agent of acne, Propionibacterium acnes (DSM 1897T), were performed as described by Silber et al. [32].
The phytopathogenic fungus Septoria tritici and the dermatophytic fungus Trichophyton rubrum as
well as the cytotoxic effect on the human hepatocellular liver carcinoma cell line HepG2 were
tested according to Jansen et al. [33]. Inhibition of the enzymes glycogen synthase kinase (GSK-3β),
acetylcholinesterase (AchE), phosphodiesterase (PDE-4B2), and protein tyrosine phosphatase (PTP1B)
was determined according to Baki et al. [34], Ohlendorf et al. [31], Schulz et al. [35], and Silber et al. [36],
respectively. The concentration of the compounds used in the initial bioassays was 100 µM
(antibiotic tests), 50 µM (cytotoxic tests), and 10 µM (enzymatic tests). To determine the IC50 values
concentrations of the compounds ranging from 0.1 µM to 50 µM were analyzed twice in duplicates.
5. Conclusions
For the first time, Biscogniauxia mediterranea, known as a plant parasitic-pathogenic fungus,
was isolated from marine deep-sea sediments. In extracts of B. mediterranea strain LF657, isolated from
the Eastern Mediterranean Sea at 2800 m water depth, one of the compounds was identified as the
new isopyrrolonaphthoquinone, biscogniauxone (1), a new member of a minor natural compound
class, and found to exhibit inhibitory activity against the enzyme GSK-3β with an IC50 value of 8 µM.
This effect is much lower in comparison to the GSK inhibitor TDZD-8. However, it is of interest
that another isopyrrolonaphthoquinone, namely bhimamycin H, also inhibited the activity of this
enzyme in a similar range (IC50 value of 18 µM) [14]. Therefore, isopyrrolonaphthoquinones and
similar structures can be considered as possible candidates for the development of drugs in order to
treat diseases related to the biological target GSK-3β, such as diabetes type 2, neurological disorders,
or cancer [19–21]. These findings are a nice example to demonstrate anew that natural products from
the microbial treasure box of the ocean and derivatives thereof can be of great benefit for human health.
Supplementary Materials: NMR data of compound 1 are available online at www.mdpi.com/1660-3397/14/11/
204/s1 in Figures S1–S7.
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